MedTech Dive

Medtech industry calls for FDA staffing transparency in MDUFA talks

Medical device lobbyists called for more staffing transparency in user fee negotiations with the Food and Drug Administration ...
JD Supra

The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health

In the ongoing debate over regulatory reform, the MAHA Commission’s proposal to eliminate FDA user fees has sparked renewed scrutiny of the relationship between industry and government. At first ...
FierceBiotech

FDA floats user fee cuts for early-stage US trials, additional fees for overseas development

The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. The proposal is designed to incentivize U.S. drug development by tacking on ...
JD Supra

An Overview of the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas to Watch

On November 12, 2025, President Trump signed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, into law ...
The National Law Review

The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...